Crossmark

Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence

Crossref DOI link: https://doi.org/10.1016/j.aohep.2021.100568

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Celsa, Ciro

Stornello, Caterina

Giuffrida, Paolo

Giacchetto, Carmelo Marco

Grova, Mauro

Rancatore, Gabriele

Pitrone, Concetta

Di Marco, Vito

Cammà, Calogero

Cabibbo, Giuseppe
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2021-10-19
More Information

This article is maintained by: Elsevier

Article Title: Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2021.100568

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.